 MOUNT HOPE: LIFE AND DEATH AT THE HOSPITAL - Pg. 2
Patient Jeanette Heller, 94, below, works on her balance,
strength and flexibility in the pool as physiotherapist
Natalie Greenidge leads a group hydrotherapy session. 
“We will experience a pandemic in influenza,” Dr. Low is
telling the crowd. “We will not prevent or control a pandemic.”
As soon as he says it, he has all their attention.
Dr. Low is a phenomenon – thin, bald, grey, slight, a perpetual-
motion microbiologist, Toronto’s own Dr. McGerm.
He rose to widespread public prominence during the SARS
crisis, when he became the most reassuring face on TV. Ever
since, he has been the media’s favourite expert every time
there’s a viral outbreak of unknown origin — which happens
four or five times a year.
In addition to being the chief of microbiology at Mount
Sinai, Dr. Low supervises 70 laboratory workers and 18,000
square feet of space, serious acreage in lab land.
He’s also medical director of the Ontario government’s
public-health laboratories and a professor at the University
of Toronto, and has five other clinical, research and teaching
posts, and 19 other current appointments. His CV is 132
pages long.
He has not one but two BlackBerrys (one for the hospital,
one for government), and a pager, and a cellphone: He has so
many cubes and boxes and gadgets hanging from his belt he
could be a munitions specialist for the Queen’s Own Rifles.
He often starts the day with a television appearance or two,
followed by six meetings before lunch, three more meetings
and interviews in the afternoon, and a speech about pandemic
influenza after dinner.
Dr. Low doesn’t like what he imagines when he thinks
about avian flu, and he thinks about it every day. So far,
roughly half the people who have contracted
Above: A nurse places three-week-old Sophia Kuhl
in her
incubator. She and twin sister Emily, of
Timmins, Ont.,
were born 10 weeks premature.
bird flu have
died from it. Early estimates say 11,000 to 58,000 people
could die in Canada.
“Impact’s gonna depend on two things,” Dr. Low says.
“How infectious is it? Is it going to be like SARS, and easily
brought under control?” (Easily? That was easy?) “And two,
how virulent will it be?”
Then there is oseltamivir, known as Tamiflu in the trade,
one of two antiviral agents that can mute or even prevent
avian flu, and its attendant ethical problems: “Who do you
give Tamiflu to? Is it your first-line medical workers? Politicians?
Police? You could argue that the people in the ICU,
they shouldn’t get it, because they’re already sick.”
This ability to think clearly about terrifying possibilities is
why the entire crowd is hanging on Dr. Low’s every word.
“Everyone who works at Mount Sinai during the pandemic
will receive Tamiflu as a prophylactic,” he says. But then he
adds that “it might be that there is just not enough of the drug
available.”
All of a sudden, hands start shooting up like exclamation
points.
One father wants to know if he should buy a $70 respirator
from Home Depot for his asthmatic kids; a woman asks how
much she should stockpile. Gradually, a fine, almost invisible
mist of concern rises in the auditorium.
As Dr. Low says, everyone’s greatest concern at the hospital
during SARS was “taking it home to their families. And that’s
going to be one of the things in a pandemic.”
If you thought the recent rioting in France was bad, wait
until there’s not enough Tamiflu to go around in a pandemic.
• • •

In a hospital, things can be right and wrong and true and not
true at exactly the same time, for exactly the same reasons.
Up here on the 18th floor, for instance, next to the intensivecare
ward, a place where people go to recover or die but
seldom anything in between, Tom Stewart, the director of
critical care at Mount Sinai and the University Health Network,
is trying to decide whether to prescribe an anti-sepsis
drug called Xigris that costs nearly $11,000 for one 96-hour
course of treatment — even though the patient, an old man,
is likely to die anyway.
What should he do? As an administrator, under constant
pressure to cut costs and maintain patient flow and free up
beds, he should not prescribe the drug. As a humane doctor
who has confidence in science, he will. And as a born-again
Christian, who believes in God’s will and the power of faith?
He’s an interesting man.
This is why the hospital is an ongoing argument, a daily
debate, a form of incessant intellectual triage: This diagnosis
or that one? Spend money here, or there?
Patient Hakan Pirincoglu, top, is given an
inner-ear test called an electronystagmography by
audiologist Erica Wong (not pictured).
Mount Sinai residents, left, practise their
diagnostic skills on a sophisticated dummy patient
called Sim-Man, which mimics a range of vital
signs and symptoms. It even speaks.
< Previous Page | Next Page >
|